Company Filing History:
Years Active: 2024
Title: Innovations of Abdul Rashee Mohammed in Muscarinic Receptor Modulation.
Introduction
Abdul Rashee Mohammed is an accomplished inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that act as positive allosteric modulators for muscarinic M1 receptors. His work is pivotal in advancing therapeutic options for various neurological conditions.
Latest Patents
Abdul Rashee Mohammed holds a patent for "Pyrrolo-pyridazine derivatives as muscarinic M1 receptor positive allosteric modulators." This invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers, or pharmaceutically acceptable salt(s) thereof. The patent describes the preparation, pharmaceutical composition, and use of these compounds, which are crucial for enhancing the efficacy of treatments targeting the muscarinic M1 receptor.
Career Highlights
Abdul Rashee Mohammed is currently associated with Suven Life Sciences Limited, where he continues to innovate in the field of drug development. His expertise in pharmacology and medicinal chemistry has positioned him as a key player in the research and development of new therapeutic agents.
Collaborations
He has collaborated with notable colleagues such as Ramakrishna Nirogi and Anil Karbhari Shinde, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Abdul Rashee Mohammed's work exemplifies the intersection of innovation and pharmacology, showcasing the potential of muscarinic M1 receptor modulators in therapeutic applications. His contributions are vital for the advancement of medical science and the development of new treatments.